SageView Advisory Group’s Bioventus BVS Stock Holding History

SageView Advisory Group’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-198	Closed	-$1.47K	–	853
2025 Q4	$1.47K	Buy	+198	New	+$1.42K	﹤0.01%	2300

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SageView Advisory Group's BVS Position: Q1 2026 in Review

SageView Advisory Group sold out of Bioventus (BVS) in Q1 2026, closing a stake of 198 shares — an estimated $1.47K sold.

SageView Advisory Group first reported a position in BVS in Q4 2025 and held it in 1 quarter. The position peaked at $1.47K in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

SageView Advisory Group reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 198 Bioventus shares in Q1 2026, an estimated $1.47K.
SageView Advisory Group first reported a position in Bioventus in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Bioventus position peaked at $1.47K in Q4 2025.
157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.